Investor Relations
Investor Overview

Investor Overview

Investor Overview

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company committed to the discovery and development of novel therapeutics to treat cystic fibrosis, or CF, through theratyping, or the process of matching modulators to individual response to treatment regardless of CFTR mutations. CF is a disease caused by defects in the function. ... More >>

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events
More events are coming soon.
Investor Presentations

Shareholder Tools